VitaCurrant® Black Currant Extract Inhibits Elastase

December 15, 2008

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

MOMENCE, Ill.—VitaCurrant® Black Currant Extract was found in a recent in vitro study to inhibit the enzyme, elastase up to 96 percent at a concentration of 0.1 percent. High elastase levels are associated with the development of atherosclerosis and increased risk of cardiovascular disease and hypertension. The study was conducted at FutureCeuticals Inc. Laboratories.

www.Futureceuticals.com

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like